Squarer Ron 4
4 · Travere Therapeutics, Inc. · Filed May 16, 2025
Insider Transaction Report
Form 4
Squarer Ron
Director
Transactions
- Award
Stock option (right to buy)
2025-05-15+19,500→ 19,500 totalExercise: $21.15From: 2026-05-15Exp: 2035-05-15→ Common Stock (19,500 underlying) - Award
Common Stock
2025-05-15+6,500→ 35,375 total
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.